Globally, Chagas disease affects 6 million people, mainly in Latin America, and is a major public health problem in Bolivia. Starting as a parasitic disease, it can lead to chronic cardiac disorders in up to one third of patients. In Bolivia, Novartis is working with the Barcelona Institute for Global Health (ISGlobal) to promote an integrated, comprehensive approach to prevent, treat, and manage Chagas disease.
Listen to Irene Jimeno from ISGlobal talk about the collaboration with Novartis in Bolivia.
Learn more: https://bit.ly/3rape1Y
©2022 Novartis AG